Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (271-280 of 283) with videos related to

Pageof 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung CancerScott N Gettinger, Leora Horn, Leena Gandhi, et al.
Journal of the National Cancer Institute|May 17, 2023
Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppressionJason V Evans, Shankar Suman, Mounika Uttam L Goruganthu, et al.
JCO Precision Oncology|March 21, 2024
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung CancerPetros Christopoulos, Michal Harel, Kimberly McGregor, et al.
The Lancet. Oncology|October 1, 2011
Delivering affordable cancer care in high-income countriesRichard Sullivan, Jeffrey Peppercorn, Karol Sikora, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2023
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant TherapySanja Dacic, William Travis, Mary Redman, et al.
Nature Medicine|March 28, 2024
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim resultsAmy R Rappaport, Chrisann Kyi, Monica Lane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2017
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET RegistryOliver Gautschi, Julie Milia, Thomas Filleron, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2016
Scientific Advances in Lung Cancer 2015Anne S Tsao, Giorgio V Scagliotti, Paul A Bunn, et al.
Nature Medicine|August 15, 2022
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim resultsChristine D Palmer, Amy R Rappaport, Matthew J Davis, et al.
Journal of Translational Medicine|February 21, 2024
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancerMike Mason, Óscar Lapuente-Santana, Anni S Halkola, et al.
Pageof 29

Showing results (271-280 of 283) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung CancerScott N Gettinger, Leora Horn, Leena Gandhi, et al.
Journal of the National Cancer Institute|May 17, 2023
Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppressionJason V Evans, Shankar Suman, Mounika Uttam L Goruganthu, et al.
JCO Precision Oncology|March 21, 2024
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung CancerPetros Christopoulos, Michal Harel, Kimberly McGregor, et al.
The Lancet. Oncology|October 1, 2011
Delivering affordable cancer care in high-income countriesRichard Sullivan, Jeffrey Peppercorn, Karol Sikora, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2023
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant TherapySanja Dacic, William Travis, Mary Redman, et al.
Nature Medicine|March 28, 2024
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim resultsAmy R Rappaport, Chrisann Kyi, Monica Lane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2017
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET RegistryOliver Gautschi, Julie Milia, Thomas Filleron, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2016
Scientific Advances in Lung Cancer 2015Anne S Tsao, Giorgio V Scagliotti, Paul A Bunn, et al.
Nature Medicine|August 15, 2022
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim resultsChristine D Palmer, Amy R Rappaport, Matthew J Davis, et al.
Journal of Translational Medicine|February 21, 2024
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancerMike Mason, Óscar Lapuente-Santana, Anni S Halkola, et al.
Pageof 29